A father with terminal cancer who had two-thirds of his penis “chopped off” has defied doctors’ “bleak” 12-month prognosis ...

FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients ≥12 years. FDA accepts priority review of sNDA for gepotidacin ...

Fortunate Mokoena receives funding from the Science for Africa Foundation (SFA) as part of the second Grand Challenges Africa grantees cohort by the Bill and Melinda Gates Foundation ...

You no doubt spend a lot of time gazing adoringly into your baby's eyes. But if they've started looking a bit red and sticky, you may be concerned your little one has conjunctivitis. Conjunctivitis, ...

The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted a positive opinion on zuranolone (Zurzuvae, Biogen Netherlands BV), the first oral drug to treat ...

Switzerland's Swissmedic has approved a ground-breaking malaria medicine for infants, marking a significant step in combatting the disease in Africa. Developed by Novartis, this infant-focused ...

The first malaria treatment suitable for babies and very young children has been approved for use. It’s expected to be rolled out in African countries within weeks. Until now there have been no ...

ZURICH, July 8 (Reuters) - Novartis (NOVN.S), opens new tab said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat malaria in babies and ...

Medicine to treat babies and infants suffering from malaria has been approved for the first time and is expected to be rolled out in Africa within weeks. Malaria treatment for infants weighing less ...

The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...